Urania Dafni
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 113 publications
Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 12, 2026
A phase I dose escalation of FLASH radiotherapy in patients with cutaneous metastases from melanoma: The IMPulse trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: November 04, 2025
Impact of TP53, KEAP1 and STK11 mutations in localized-stage NSCLC: A European thoracic oncology platform lungscape project.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 04, 2025
Combinatorial Delivery of Low-Dose Radiotherapy and Immunotherapy to Patients with Immune-Excluded Tumors Enhances CD8+ T-cell Functionality.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 24, 2025
ETOP 25-23 ADOPT-lung: An international, multicentre, open-label randomised phase III trial to evaluate the benefit of adding adjuvant durvalumab after neoadjuvant chemotherapy plus durvalumab in patients with stage IIB-IIIB (N2) resectable NSCLC.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 18, 2025
Neoadjuvant or Perioperative Chemoimmunotherapy Treatment in Patients with Resectable NSCLC: Still an Open Question. Comments on Marinelli et al. J Thorac Oncol. 2025;20:285-295.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 26, 2025
Safety of adoptive therapy with tumor-infiltrating lymphocytes and high-dose recombinant interleukin 2 in advanced cutaneous melanoma: a systematic review and meta-analysis.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 23, 2024
ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 21, 2024
Immunotherapy or targeted therapy with or without stereotactic radiosurgery for patients with brain metastases from melanoma or non-small cell lung cancer - The ETOP 19-21 USZ-STRIKE study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 17, 2024
A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance - The ETOP 15-19 ABC-lung trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 06, 2024
Multimodality treatment in synchronous oligometastatic NSCLC: Analysis of the ETOP CHESS trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 05, 2024
A randomised phase III study of bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 25, 2024
Last Updated: 09/26/2026